Xizhe Li

1.4k citations
25 papers · 982 indexed · 1 hit paper · h-index 14
Topics
Circular RNAs in diseases (6 papers)RNA modifications and cancer (5 papers)Cancer, Hypoxia, and Metabolism (4 papers)

In The Last Decade

Xizhe Li

25 papers receiving 974 citations

Hit Papers

Immunotherapy for glioma: Current management and future a...20202026202220242020100200300400500

Peers

Xizhe Li
Comparison fields: 5 of 95
  • Molecular Biology 585
  • Cancer Research 337
  • Pulmonary and Respiratory Medicine 263
  • Genetics 222
  • Immunology 219
Replace Dauren Biyashev with:
Dauren Biyashev United States
Ye Song China
Lu Tang China
Guanqun Ge China
Hendrik Nogai Germany
Severa Bunda Canada
Rongfang Qiu China
Cristiana Angelucci Italy
Frédérique Deshayes France
Xizhe Li relative to Dauren Biyashev United States Dauren Biyashev's profile →
Citations per field
00.5×3.7×
Dauren Biyashev · 1×
Citations per year

Countries citing papers authored by Xizhe Li

Since Specialization
Citations

This map shows the geographic impact of Xizhe Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xizhe Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xizhe Li more than expected).

Fields of papers citing papers by Xizhe Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xizhe Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xizhe Li. The network helps show where Xizhe Li may publish in the future.

Co-authorship network of co-authors of Xizhe Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xizhe Li. A scholar is included among the top collaborators of Xizhe Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xizhe Li. Xizhe Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 46
4 14
5 34
6 7
7 3
8 36
9 27
10 13
11 21
12 45
13 32
14
Immunotherapy for glioma: Current management and future applicationbreakdown →
501
15 17
16 67
17 1
18 28
19 3
20 10

About Xizhe Li

Xizhe Li is a scholar working on Cancer Research, Applied Microbiology and Biotechnology and Molecular Biology, having authored 25 papers that have together received 982 indexed citations. Recurring topics across this work include Circular RNAs in diseases (6 papers), RNA modifications and cancer (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). The work is most often cited by research in Cancer Research (337 citations), Genetics (222 citations) and Immunology (219 citations). Xizhe Li has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Shengchao Xu, Lu Tang, Zhixiong Liu, Fan Fan, Ruimin Chang, Chunfang Zhang, Chaojun Duan, Chunfang Zhang, Jian Shi and Yu Xia. Their work appears in journals such as Scientific Reports, Cell Death and Differentiation and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026